Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes.

Abstract:

:The efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitors canagliflozin, dapagliflozin, and empagliflozin in reducing hyperglycemia in patients with type 2 diabetes is well documented. In addition, positive effects have been observed with these agents on nonglycemic variables, such as reductions in body weight and blood pressure, which may confer additional health benefits. SGLT2 inhibitors are also associated with evidence of renal-protecting benefits. Furthermore, during the landmark Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes (EMPA-REG OUTCOME) trial, a substantial reduction in major adverse cardiovascular outcomes was demonstrated with empagliflozin therapy. In view of the complex pathogenesis of cardiovascular disease in patients with diabetes, a pharmacologic intervention for type 2 diabetes that produces a multifaceted reduction in cardiovascular disease risk, separate from glycemic control alone, would be advantageous. Although SGLT2 inhibitors are generally well tolerated, they are associated with an increased risk of genital mycotic infections, as well as the potential risk for serious adverse events such as dehydration, development of diabetic ketoacidosis, serious urinary tract infections, and bone fractures. The findings of ongoing research will help to determine the magnitude and clinical importance of these adverse events and whether the findings of EMPA-REG OUTCOME represent a class effect for SGLT2 inhibition or are specific to empagliflozin and will further elucidate the future role of SGLT2 inhibitors in the individualized management of patients with type 2 diabetes. In this article, we discuss the nonglycemic outcomes associated with SGLT2 inhibitor therapy in patients with type 2 diabetes as well as the clinical implications of these agents.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Trujillo JM,Nuffer WA

doi

10.1002/phar.1903

subject

Has Abstract

pub_date

2017-04-01 00:00:00

pages

481-491

issue

4

eissn

0277-0008

issn

1875-9114

journal_volume

37

pub_type

杂志文章,评审
  • Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients.

    abstract:STUDY OBJECTIVES:To evaluate the safety and efficacy of aerosolized ceftazidime for prevention of ventilator-associated pneumonia (VAP) and to evaluate the effects of the drug on the proinflammatory response. DESIGN:Prospective, randomized, double-blind, placebo-controlled clinical trial. SETTING:University teaching ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.22.12.972.33596

    authors: Wood GC,Boucher BA,Croce MA,Hanes SD,Herring VL,Fabian TC

    更新日期:2002-08-01 00:00:00

  • Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy.

    abstract:OBJECTIVE:To identify and describe the scope of practice that characterizes the critical care pharmacist and critical care pharmacy services. Specifically, the goals were to define the level of clinical practice and specialized skills characterizing the critical care pharmacist as clinician, educator, researcher, and m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors:

    更新日期:2000-11-01 00:00:00

  • Evaluation of the half-life of intravenous human cytomegalovirus immune globulin in patients receiving partially mismatched related donor bone marrow transplantation.

    abstract:STUDY OBJECTIVE:To evaluate the pharmacokinetics and use of intravenous human cytomegalovirus immune globulin (CytoGam) in allogeneic bone marrow transplantation (BMT). DESIGN:Prospective, nonrandomized, nonblinded, single-center study. SETTING:University teaching hospital. PATIENTS:Five consecutive patients with he...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.15.1175.34592

    authors: DeRienzo SY,Chiang KY,O'Neal WM,Godder K,Abhyankar S,Christiansen NP,Bridges KD,Henslee-Downey PJ

    更新日期:2000-10-01 00:00:00

  • Discrepancies in identification of major bleeding events in patients taking warfarin.

    abstract:STUDY OBJECTIVE:To assess the level of agreement between one subjective definition of major bleeding (criteria A) and two objective definitions: the International Society on Thrombosis and Haemostasis ([ISTH] criteria B) and the Italian Study of Complications of Anticoagulant Therapy ([ISCOAT] criteria C). DESIGN:Retr...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.9.1098

    authors: Seto AC,Kenyon K,Wittkowsky AK

    更新日期:2008-09-01 00:00:00

  • The effect of Cys LT1 receptor blockade on airway responses to allergen.

    abstract:STUDY OBJECTIVE:To evaluate the effect of a potent experimental leukotriene receptor antagonist, MK-571, on airway responses to inhaled allergen. DESIGN:Randomized, double-blind, placebo-controlled, crossover trial. SETTING:Clinical research center. SUBJECTS:Eight male volunteers with allergic asthma. INTERVENTIONS...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.19.16.1243.30878

    authors: Hendeles L,Davison D,Harman E,Sherman JM

    更新日期:1999-11-01 00:00:00

  • Effect of triplicate prescription policy on benzodiazepine administration in nursing home residents.

    abstract:OBJECTIVE:To estimate the effect of a triplicate prescription policy on administration of benzodiazepines and possible substitute drugs in nursing home residents during 1994-1995. DESIGN:Retrospective cross-sectional study SETTING:Medicare- and Medicaid-certified nursing homes in five states: New York, which has a po...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.15.1159.33898

    authors: VanHaaren AM,Lapane KL,Hughes CM

    更新日期:2001-10-01 00:00:00

  • Falsely decreased total serum calcium concentration associated with iron dextran injection.

    abstract::We cared for a patient in whom iron dextran administration interfered with the determination of total serum calcium concentration. An unexpected elevation in serum phosphorus concentration also occurred after the iron dextran infusion. A MEDLINE search from 1966 to present was conducted, and the manufacturer of the ir...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Newsom L,Erstad BL,Nakazato PZ,Daller JA

    更新日期:1995-11-01 00:00:00

  • The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.

    abstract:STUDY OBJECTIVE:To evaluate the safety, tolerability, and pharmacokinetic profile of fosphenytoin, a water-soluble phenytoin prodrug, after intramuscular and intravenous administration. DESIGN:Open-label study of intramuscular administration, and double-blind, randomized study of intravenous administration. SETTING:S...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Boucher BA,Feler CA,Dean JC,Michie DD,Tipton BK,Smith KR Jr,Kramer RE,Young B,Parks BR Jr,Kugler AR

    更新日期:1996-07-01 00:00:00

  • Optimizing pediatric dosing: a developmental pharmacologic approach.

    abstract::Many physiologic differences between children and adults can result in age-related differences in pharmacokinetics. Understanding the effects of age on bioavailability, volume of distribution, protein binding, hepatic metabolic isoenzymes, and renal elimination can provide insight into optimizing doses for pediatric p...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.29.6.680

    authors: Anderson GD,Lynn AM

    更新日期:2009-06-01 00:00:00

  • Enoxaparin-associated retroperitoneal bleeding in two patients with renal insufficiency.

    abstract::Two patients with chronic kidney disease experienced a major bleeding event, retroperitoneal hematoma, requiring a blood transfusion after the administration of enoxaparin. The first patient was a 61-year-old Caucasian woman with multiple comorbidities, including chronic kidney disease stage 4. She received subcutaneo...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.5.769.63596

    authors: Malik A,Capling R,Bastani B

    更新日期:2005-05-01 00:00:00

  • Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.

    abstract:STUDY OBJECTIVES:To determine the incidence of Clostridium difficile infection (CDI) at one community hospital by identifying patients with stool samples positive for C. difficile toxin A or B, and to compare the incidence with a 2008 national estimate; and to determine which patient characteristics and concomitant ant...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.31.7.642

    authors: King RN,Lager SL

    更新日期:2011-07-01 00:00:00

  • Elevations in serum creatinine concentration: concerning or reassuring?

    abstract::The use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) has significantly reduced morbidity and mortality across the continuum of vascular disease. The utilization of these agents, however, remains suboptimal. The drugs are not prescribed in many patients because of concerns ...

    journal_title:Pharmacotherapy

    pub_type: 评论,杂志文章

    doi:10.1592/phco.24.6.697.34731

    authors: Epstein BJ

    更新日期:2004-05-01 00:00:00

  • Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic.

    abstract:STUDY OBJECTIVES:To determine changes in bone mineral density (BMD) and T scores of patients after 2 years of teriparatide therapy, and to determine the number of fractures that occurred during therapy. DESIGN:Prospective, observational study. SETTING:Pharmacist-run teriparatide clinic in a private-practice endocrino...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.27.6.779

    authors: Stroup JS,Rivers SM,Abu-Baker AM,Kane MP

    更新日期:2007-06-01 00:00:00

  • Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics.

    abstract::Anticoagulation clinics emerged as a means to optimize warfarin effectiveness and minimize bleeding risks. Anticoagulation clinics have traditionally been warfarin-based models due to the need for frequent blood-level monitoring, drug interactions, dietary considerations, and periprocedural management with warfarin. T...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1991

    authors: Mohammad I,Korkis B,Garwood CL

    更新日期:2017-10-01 00:00:00

  • Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States.

    abstract::The antiretroviral combination of emtricitabine-tenofovir disoproxil fumarate (FTC/TDF) was approved by the U.S. Food and Drug Administration for use as pre-exposure prophylaxis (PrEP) in individuals at high risk for acquiring human immunodeficiency virus (HIV) in July 2012. Since then, Centers for Disease Control and...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2240

    authors: Adams JL,Shelley K,Nicol MR

    更新日期:2019-04-01 00:00:00

  • Telavancin: an antimicrobial with a multifunctional mechanism of action for the treatment of serious gram-positive infections.

    abstract::Telavancin is a once-daily lipoglycopeptide antibiotic structurally derived from vancomycin. It has broad-spectrum activity against gram-positive bacteria, including strains with reduced susceptibility to vancomycin. Telavancin's multifunctional mechanism of action, including inhibition of peptidoglycan synthesis and ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.28.4.458

    authors: Leonard SN,Rybak MJ

    更新日期:2008-04-01 00:00:00

  • Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service.

    abstract:STUDY OBJECTIVE:To compare adverse events related to anticoagulation in patients assigned to a pharmacist-managed anticoagulation service versus those receiving usual care. DESIGN:Retrospective cohort analysis. SETTING:Three hundred-bed community hospital. PATIENTS:Four hundred twenty patients referred for anticoagu...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.5.685.63582

    authors: Locke C,Ravnan SL,Patel R,Uchizono JA

    更新日期:2005-05-01 00:00:00

  • Urogenital atrophy: prevention and treatment.

    abstract::Fifteen percent of premenopausal women, 10-40% of postmenopausal women, and 10-25% of women receiving systemic hormone therapy experience urogenital atrophy. The most common symptoms are dryness, burning, pruritus, irritation, and dyspareunia. Estrogen loss, drugs, and chemical sensitivities are causes. Estrogen or ho...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.5.464.34486

    authors: Willhite LA,O'Connell MB

    更新日期:2001-04-01 00:00:00

  • Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.

    abstract:STUDY OBJECTIVE:To compare clinical and safety outcomes of warfarin therapy before and after implementation of a novel patient self-management (PSM) program in which patients received their venipuncture-derived international normalized ratio (INR) results through a secure online messaging system and adjusted their warf...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1139

    authors: Simmons BJ,Jenner KM,Delate T,Clark NP,Kurz D,Witt DM

    更新日期:2012-12-01 00:00:00

  • Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.

    abstract:STUDY OBJECTIVE:To evaluate the impact of a hospital-acquired pneumonia (HAP) protocol on appropriateness of empiric antibiotic therapy, antibiotic deescalation, antibiotic duration, patient mortality, and length of stay. DESIGN:Before- and after-study of protocol implementation. SETTING:A 450-bed, academic medical c...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.7.852

    authors: Lancaster JW,Lawrence KR,Fong JJ,Doron SI,Garpestad E,Nasraway SA,Devlin JW

    更新日期:2008-07-01 00:00:00

  • Is chlordiazepoxide the rational choice among benzodiazepines?

    abstract::Diazepam is frequently the subject of review by various agencies and institutions charged with determining whether or not to substitute another, more economical drug--in most instances, chlordiazepoxide. A review of the comparative literature has shown that, on clinical and pharmacokinetic grounds, chlordiazepoxide is...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1982.tb03181.x

    authors: Baskin SI,Esdale A

    更新日期:1982-03-01 00:00:00

  • Mechanisms of action of hormonal emergency contraceptives.

    abstract::Hormonal emergency contraceptives have been used to prevent unwanted pregnancy for more than 3 decades. The mechanisms of action of the regimen containing a combination of estrogen and progestin, known as the Yuzpe regimen, and those of the levonorgestrel regimen continue to be controversial, especially over the possi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.30.2.158

    authors: Leung VW,Levine M,Soon JA

    更新日期:2010-02-01 00:00:00

  • Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Review.

    abstract::Central nervous system stimulants are a commonly used first-line treatment option for attention-deficit/hyperactivity disorder (ADHD). Stimulants are generally well tolerated, with anorexia and insomnia the most common adverse effects. However, there are some concerns with long-term use of stimulants, such as potentia...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2192

    authors: Troksa K,Kovacich N,Moro M,Chavez B

    更新日期:2019-06-01 00:00:00

  • Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis.

    abstract::We conducted a systematic review of randomized, controlled, monotherapy trials since 1990 of oral antihypertensive agents in patients with essential hypertension. Our objective was to quantify the frequency of discontinuation of antihypertensive agents due to adverse events from a meta-analysis of the studies. A total...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,meta分析

    doi:10.1592/phco.21.11.940.34520

    authors: Ross SD,Akhras KS,Zhang S,Rozinsky M,Nalysnyk L

    更新日期:2001-08-01 00:00:00

  • Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease.

    abstract::The National Kidney Foundation developed and oversees the Kidney Disease Outcomes Quality Initiative, a process that develops clinical practice guidelines in nephrology. Recent guidelines address the evaluation, classification, and stratification of chronic kidney disease (CKD). These guidelines provide, for the first...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.25.4.491.61034

    authors: Bailie GR,Uhlig K,Levey AS

    更新日期:2005-04-01 00:00:00

  • A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.

    abstract:STUDY OBJECTIVE:A safe alternative to erythropoiesis-stimulating agents to treat anemia is warranted in patients with cancer and anemia; thus the objective of this trial was to compare the efficacy and safety of intravenous (IV) iron isomaltoside with oral iron in patients with cancer and anemia by testing the noninfer...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1729

    authors: Birgegård G,Henry D,Glaspy J,Chopra R,Thomsen LL,Auerbach M

    更新日期:2016-04-01 00:00:00

  • Amiodarone use in patients with documented allergy to iodine-containing compounds.

    abstract::The popularity of amiodarone has grown due to its effectiveness in converting arrhythmia and its formulation availability. Formulations of the drug also contain iodine; the iodine content is 75 mg in a 200-mg tablet of amiodarone and 18.7 mg/ml in the intravenous solution. Approximately 10% of the iodine content of or...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.3.429.61602

    authors: Brouse SD,Phillips SM

    更新日期:2005-03-01 00:00:00

  • Strategies in the management of acute myocardial infarction.

    abstract::Clinical trials continue to evaluate the pharmacologic management of myocardial infarction for benefits in mortality, degree of infarct artery patency, and frequency of reocclusion. The discovery of thrombus formation in the development of the myocardial infarction renewed interest in thrombolytic therapy. In appropri...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Talbert RL

    更新日期:1996-09-01 00:00:00

  • Validity of cancer-related fatigue instruments.

    abstract::Fatigue is one of the most debilitating and common symptoms associated with hematologic and oncologic disorders and treatment strategies. Patient factors influence etiology and symptom manifestation, which in turn affect diagnosis, management, and monitoring. Fatigue instruments can assist with the identification, man...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.16.1433.33690

    authors: Schwartz AH

    更新日期:2002-11-01 00:00:00

  • Accuracy of 2- and 8-hour urine collections for measuring creatinine clearance in the hospitalized elderly.

    abstract::The accuracy of 2- and 8- hour urine collections for estimating creatinine clearance was compared with that of the standard 24-hour procedure in 45 hospitalized elderly patients (age > or = 65 yrs) with indwelling urethral catheters. Urine was collected at blocked intervals from 0-2, 2-8, and 8-24 hours and then added...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: O'Connell MB,Wong MO,Bannick-Mohrland SD,Dwinell AM

    更新日期:1993-03-01 00:00:00